Results 11 to 20 of about 75,808 (286)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases

Frontiers in Neurology, 2022
Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou, Maria-Evgenia Brinia, Ioanna Svolaki, Theodore Argyrakos, Leonidas Stefanis, Constantinos Kilidireas   +5 more
doaj   +1 more source

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

Clinical Immunology Communications, 2023
We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments.
Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, José Vivancos, Francisco Sanchez-Madrid, Arantzazu Alfranca   +12 more
doaj   +1 more source

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature

Frontiers in Neurology, 2020
Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists.
Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos, Georgios Koutsis, Maria-Eleptheria Evangelopoulos, Elisabeth Andreadou, Maria Anagnostouli, Marianthi Breza, John S. Tzartos, Elias Gialafos, Antonios N. Dimitrakopoulos, Georgios Velonakis, Panagiotis Toulas, Leonidas Stefanis, Constantinos Kilidireas   +14 more
doaj   +1 more source

Tracking the impact of multiple sclerosis on employment status: the development of a questionnaire

Arquivos de Neuro-Psiquiatria, 2022
Background Multiple sclerosis (MS) has a negative effect on employment status.
Evangelina Valeria Cores, Judith Steinberg, Carolina Cuesta, María Celeste Curbelo, Mabel Alicia Osorio, Johana Julia Bauer, Daniel Gustavo Politis   +6 more
doaj   +1 more source

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts

BMC Neurology, 2020
Background Baló’s Concentric Sclerosis (BCS) is a rare heterogeneous demyelinating disease with a variety of phenotypes on Magnetic Resonance Imaging (MRI).
D. Tzanetakos, A. G. Vakrakou, J. S. Tzartos, G. Velonakis, M. E. Evangelopoulos, M. Anagnostouli, G. Koutsis, E. Dardiotis, E. Karavasilis, P. Toulas, L. Stefanis, C. Kilidireas   +11 more
doaj   +1 more source

Features of multiple sclerosis in childhood in the Republic of Tatarstan

Неврология, нейропсихиатрия, психосоматика, 2023
Multiple sclerosis (MS) in children and adolescents is a genuine concern of pediatric neurology that specialists in all countries are dealing with. To date, neither the causes of onset nor the individual components of the pathogenesis of the disease have
A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin   +2 more
doaj   +1 more source

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis

Frontiers in Immunology, 2023
Current understanding of Multiple Sclerosis (MS) pathophysiology implicates perturbations in adaptive cellular immune responses, predominantly T cells, in Relapsing-Remitting forms (RRMS).
Aigli G. Vakrakou, Aigli G. Vakrakou, Nikolaos Paschalidis, Eleftherios Pavlos, Eleftherios Pavlos, Christina Giannouli, Dimitris Karathanasis, Xristina Tsipota, Georgios Velonakis, Christine Stadelmann-Nessler, Maria-Eleftheria Evangelopoulos, Leonidas Stefanis, Constantinos Kilidireas, Constantinos Kilidireas   +13 more
doaj   +1 more source

Atypical demyelinating disease [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1974
A 17 year old girl died after an illness characterized by progressive mental deterioration and severe myoclonic jerks. Extensive pathological, virological, and immunological studies failed to support the diagnosis of subacute sclerosing panencephalitis but were compatible with disseminated demyelinating disease.
J M, Adams, W J, Brown, N E, Cremer, E D, Eberle, M E, Fewster, E H, Lennette   +5 more
openaire   +2 more sources

Fulminant Demyelinating Diseases [PDF]

The Neurohospitalist, 2013
Fulminant demyelinating disease is a heading that covers acute disseminated encephalomyelitis and its variant acute hemorrhagic leukoencephalitis (Hurst disease), severe relapses of multiple sclerosis (MS), variants of MS (tumefactive MS, Marburg variant, Balo concentric sclerosis, myelinoclastic diffuse sclerosis), and neuromyelitis optica-spectrum ...
Megan R, Rahmlow, Orhun, Kantarci
openaire   +2 more sources

Electroneurophysiological criteria of efficiency of pathogenetic therapy in diabetic polyneuropathy. [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2016
Purpose: to estimate efficiency of pathogenetic therapy of diabetic polyneuropathy with including of benfotiaminby means of an electroneuromyography.
Lubov Kuzina, Gulnaz Kaishibayeva
doaj   +1 more source